<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37100745</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8175</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Echocardiography (Mount Kisco, N.Y.)</Title><ISOAbbreviation>Echocardiography</ISOAbbreviation></Journal><ArticleTitle>Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19.</ArticleTitle><Pagination><StartPage>464</StartPage><EndPage>474</EndPage><MedlinePgn>464-474</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/echo.15575</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cardiovascular sequelae may occur in patients recovered from coronavirus disease 2019 (COVID-19). Recent studies have detected a considerable incidence of subclinical myocardial dysfunction-assessed with speckle-tracking echocardiography-and of long-COVID symptoms in these patients. This study aimed to define the long-term prognostic role of subclinical myocardial dysfunction and long-COVID condition in patients recovered from COVID-19 pneumonia.</AbstractText><AbstractText Label="METHODS">We prospectively followed up 110 patients hospitalized at our institution due to COVID-19 pneumonia in April 2020 and then recovered from SARS-CoV-2 infection. A 7-month clinical and echocardiographic evaluation was performed, followed by a 21-month clinical follow-up. The primary outcome was major adverse cardiovascular events (MACE), a composite of myocardial infarction, stroke, heart failure hospitalization, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS">A subclinical myocardial dysfunction-defined as an impairment of left ventricular global longitudinal strain (&#x2265;-18%)-was identified at a 7-month follow-up in 37 patients (34%), was associated with an increased risk of long-term MACE with a good discriminative power (area under the curve: .73) and resulted in a strong independent predictor of extended MACE in multivariate regression analyses. Long-COVID condition was not associated with a worse long-term prognosis, instead.</AbstractText><AbstractText Label="CONCLUSIONS">In patients recovered from COVID-19 pneumonia, a subclinical myocardial dysfunction is present in one-third of the whole population at 7-month follow-up and is associated with a higher risk of MACE at long-term follow-up. Speckle-tracking echocardiography is a promising tool to optimize the risk-stratification in patients recovered from COVID-19 pneumonia, while the definition of a long-COVID condition has no prognostic relevance.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Echocardiography published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cannata</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5842-5293</Identifier><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarito</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurina</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Condello</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7830-4341</Identifier><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bombace</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villaschi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stankowski</LastName><ForeName>Kamil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liccardo</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasparini</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donia</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celata</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>My</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Universit&#xe4;res Herzzentrum, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kallikourdis</LastName><ForeName>Marinos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figliozzi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazzari</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peri Operative Cardiology and Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bragato</LastName><ForeName>Renato M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Condorelli</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanini</LastName><ForeName>Giulio G</ForeName><Initials>GG</Initials><Identifier Source="ORCID">0000-0002-3558-6967</Identifier><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>COVID-19 from Regione Lombardia Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Echocardiography</MedlineTA><NlmUniqueID>8511187</NlmUniqueID><ISSNLinking>0742-2822</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">advanced echocardiography</Keyword><Keyword MajorTopicYN="N">global longitudinal strain</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">subclinical myocardial dysfunction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>26</Day><Hour>22</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37100745</ArticleId><ArticleId IdType="doi">10.1111/echo.15575</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Baigent C, Windecker S. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res. 2022;118:1618-1666.</Citation></Reference><Reference><Citation>Guo T, Fan Y, Chen M, et&#xa0;al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-818.</Citation></Reference><Reference><Citation>Shi S, Qin M, Shen B, et&#xa0;al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810.</Citation></Reference><Reference><Citation>Stefanini GG, Chiarito M, Ferrante G, et&#xa0;al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020;106:1512-1518.</Citation></Reference><Reference><Citation>Figliozzi S, Masci PG, Ahmadi N, et&#xa0;al. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50:1-15.</Citation></Reference><Reference><Citation>Izquierdo A, Moj&#xf3;n D, Bardaj&#xed; A, et&#xa0;al. Myocardial injury as a prognostic factor in mid-and long-term follow-up of covid-19 survivors. J Clin Med. 2021;10:2-11.</Citation></Reference><Reference><Citation>Weber B, Siddiqi H, Zhou G, et&#xa0;al. Relationship between myocardial injury during index hospitalization for SARS-CoV-2 infection and longer-term outcomes. J Am Heart Assoc. 2022;11(1):e022010. doi:10.1161/JAHA.121.022010</Citation></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583-590.</Citation></Reference><Reference><Citation>Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol. 2022;19:332-341.</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID - mechanisms, risk factors, and management. BMJ. 2021;374:1-18.</Citation></Reference><Reference><Citation>Szekely Y, Lichter Y, Sadon S, et&#xa0;al. Cardiorespiratory abnormalities in patients recovering from coronavirus disease 2019. J Am Soc Echocardiogr. 2021;34:1273-1284. e9.</Citation></Reference><Reference><Citation>Agricola E, Beneduce A, Esposito A, et&#xa0;al. Heart and lung multimodality imaging in COVID-19. JACC Cardiovasc Imaging. 2020;13:792-808.</Citation></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et&#xa0;al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265-1273.</Citation></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, et&#xa0;al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42:1866-1878.</Citation></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S, Long COVID. Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157-1172.</Citation></Reference><Reference><Citation>Italia L, Ingallina G, Napolano A, et&#xa0;al. Subclinical myocardial dysfunction in patients recovered from COVID-19. Echocardiography. 2021;38:1778-1786.</Citation></Reference><Reference><Citation>Croft LB, Krishnamoorthy P, Ro R, et&#xa0;al. Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients. Future Cardiol. 2021;17:655-661.</Citation></Reference><Reference><Citation>&#xd6;zer S, Candan L, &#xd6;zy&#x131;ld&#x131;z AG, Turan OE. Evaluation of left ventricular global functions with speckle tracking echocardiography in patients recovered from COVID-19. Int J Cardiovasc Imaging. 2021;37:2227-2233.</Citation></Reference><Reference><Citation>Khani M, Tavana S, Tabary M, Naseri Kivi Z, Khaheshi I. Prognostic implications of biventricular strain measurement in COVID-19 patients by speckle-tracking echocardiography. Clin Cardiol. 2021;44:1475-1481.</Citation></Reference><Reference><Citation>Xie Y, Wang L, Li M, et&#xa0;al. Biventricular longitudinal strain predict mortality in COVID-19 patients. Front Cardiovasc Med. 2021;7:1-14.</Citation></Reference><Reference><Citation>Wibowo A, Pranata R, Astuti A, et&#xa0;al. Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis. J Intensive Care. 2021;9:1-7.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et&#xa0;al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95. doi:10.1016/j.jbi.2019.103208</Citation></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et&#xa0;al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727-1736.</Citation></Reference><Reference><Citation>Lang RM, Badano LP, Victor MA, et&#xa0;al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.</Citation></Reference><Reference><Citation>D'Elia N, Caselli S, Kosmala W, et&#xa0;al. Normal Global Longitudinal Strain: an individual patient meta-analysis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):167-169.</Citation></Reference><Reference><Citation>Asch FM, Miyoshi T, Addetia K, et&#xa0;al. Similarities and differences in left ventricular size and function among races and nationalities: results of the World Alliance Societies of Echocardiography Normal Values Study. J Am Soc Echocardiogr. 2019;32:1396-1406.</Citation></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et&#xa0;al. Post-COVID syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:1-10.</Citation></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259-264.</Citation></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, et&#xa0;al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur Heart J. 2022;43:1124-1137.</Citation></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Lindmark K. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398:599-607.</Citation></Reference><Reference><Citation>Giustino G, Croft LB, Stefanini GG, et&#xa0;al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76:2043-2055.</Citation></Reference><Reference><Citation>Brito D, Meester S, Yanamala N, et&#xa0;al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging. 2021;14:541-555.</Citation></Reference><Reference><Citation>Russo C, Jin Z, Elkind MSV, et&#xa0;al. Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail. 2014;16:1301-1309.</Citation></Reference><Reference><Citation>Szymanski C, L&#xe9;vy F, Tribouilloy C. Should LVEF be replaced by global longitudinal strain. Heart. 2014;100:1655-1656.</Citation></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Alcaide P, Asselbergs FW, et&#xa0;al. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc Res. 2023 Mar 31;119(2):336-356. doi:10.1093/CVR/CVAC115</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>